London, UK, 22 May 2023.
The laboratory’s state-of-the-art facilities and scientific academic and innovation ecosystem will allow 30 Technology to accelerate its ground-breaking research and development of its nitric oxide-generating technologies and their application in addressing unmet clinical needs in respiratory disease, animal health, rare diseases, oral health, and ophthalmology.
30 Technology is also delighted to welcome as part of this expansion Emmanuel Callens, PhD, CChem, who joins as Principal Scientist, and Danielle Winning, PhD who joins as Development Analyst. Emmanuel and Danielle will be using novel scientific techniques to develop our platform technology for use in new clinical applications.
Dr Keith Lipman, Group Executive Director and Head of Research
“Our new innovation centre and research team are important steps in accelerating our development program of our existing and new technologies for use in a range of high value therapeutic applications.”
Professor Graham Cooke, Infectious Diseases at Imperial College and company advisor
“30 Technology moving into Scale Space shows the appeal for exciting companies to base themselves in the Imperial College White City environment of academic and innovation excellence”.